Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Calvez

Showing results (241-250 of 329) with videos related to

Pageof 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2019
Shared HCV Transmission Networks Among HIV-1-Positive and HIV-1-Negative Men Having Sex With Men by Ultradeep SequencingThuy Nguyen, Constance Delaugerre, Marc-Antoine Valantin, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2018
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patientsCathia Soulie, Maria Mercedes Santoro, Charlotte Charpentier, et al.
Journal of Global Antimicrobial Resistance|February 4, 2021
Low level of baseline resistance in recently HCV-infected men who have sex with men with high-risk behavioursThuy Nguyen, Marc-Antoine Valantin, Constance Delaugerre, et al.
Viruses|February 26, 2022
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies TherapiesAude Jary, Stéphane Marot, Antoine Faycal, et al.
Antiviral Therapy|May 11, 2011
High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in NigerCharlotte Charpentier, Pantxika Bellecave, Mohamed Cisse, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2008
Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancyJade Ghosn, Ines De Montgolfier, Chantal Cornélie, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2024
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugsCathia Soulie, Rachid Agher, Antoine Fauchois, et al.
Jac-Antimicrobial Resistance|December 11, 2024
Clearance of archived integrase strand transfer inhibitors resistance mutations in people with virologically suppressed HIV infectionBasma Abdi, Romain Palich, Sophie Seang, et al.
BMC Infectious Diseases|December 21, 2019
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in MaliAude Jary, Sidi Dienta, Valentin Leducq, et al.
Antiviral Therapy|March 27, 2009
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypesAlmoustapha-Issiaka Maïga, Isabelle Malet, Cathia Soulie, et al.
Pageof 33

Showing results (241-250 of 329) with videos related to

Sort By:
Pageof 33
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2019
Shared HCV Transmission Networks Among HIV-1-Positive and HIV-1-Negative Men Having Sex With Men by Ultradeep SequencingThuy Nguyen, Constance Delaugerre, Marc-Antoine Valantin, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2018
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patientsCathia Soulie, Maria Mercedes Santoro, Charlotte Charpentier, et al.
Journal of Global Antimicrobial Resistance|February 4, 2021
Low level of baseline resistance in recently HCV-infected men who have sex with men with high-risk behavioursThuy Nguyen, Marc-Antoine Valantin, Constance Delaugerre, et al.
Viruses|February 26, 2022
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies TherapiesAude Jary, Stéphane Marot, Antoine Faycal, et al.
Antiviral Therapy|May 11, 2011
High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in NigerCharlotte Charpentier, Pantxika Bellecave, Mohamed Cisse, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2008
Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancyJade Ghosn, Ines De Montgolfier, Chantal Cornélie, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2024
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugsCathia Soulie, Rachid Agher, Antoine Fauchois, et al.
Jac-Antimicrobial Resistance|December 11, 2024
Clearance of archived integrase strand transfer inhibitors resistance mutations in people with virologically suppressed HIV infectionBasma Abdi, Romain Palich, Sophie Seang, et al.
BMC Infectious Diseases|December 21, 2019
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in MaliAude Jary, Sidi Dienta, Valentin Leducq, et al.
Antiviral Therapy|March 27, 2009
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypesAlmoustapha-Issiaka Maïga, Isabelle Malet, Cathia Soulie, et al.
Pageof 33